Tonix Pharmaceuticals

TNXPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$181.629 M

$10.59 -1.21%

Close of 22 Sept 2026

Revenue

$13.1M

#3100 by revenue

Earnings

-$124.0M

Loss-making

Shares outstanding

17,151,024

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#274AN2 TherapeuticsANTX$182.3M
#275Minerva NeurosciencesNERV$181.9M
#276Tonix PharmaceuticalsTNXP$181.6M
#277Jyong BiotechMENS$180.9M
#278Lifecore Biomedical, Inc. DeLFCR$170.1M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Tonix Pharmaceuticals, worth $27.6K. Grants and option exercises are excluded.

Seth LedermanChief Executive Officer$27.6K
2,000 shares at $13.79 on 27 Aug 2026 · filed 31 Aug 2026

What if Tonix Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,762,808

Per share 166,460× higher

Bitcoin $1.74T

$101,548.17

Per share 9,589× higher

Nvidia $5.52T

$321,599.87

Per share 30,368× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Tonix Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.